Literature DB >> 3314618

Surfactant for the treatment of respiratory distress syndrome.

A Jobe1, M Ikegami.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3314618     DOI: 10.1164/ajrccm/136.5.1256

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  25 in total

1.  Exogenous surfactant treatment for the adult respiratory distress syndrome? A historical perspective.

Authors:  N S Morton
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

2.  Cost effectiveness of beractant in the prevention of respiratory distress syndrome.

Authors:  R F Soll; J Jacobs; S Pashko; R Thomas
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

3.  A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome.

Authors:  L Gortner; U Bernsau; H H Hellwege; G Hieronimi; G Jorch; H L Reiter
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 4.  Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.

Authors:  T A Merritt; M Hallman; R Spragg; G P Heldt; N Gilliard
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

Review 5.  Function and regulation of expression of pulmonary surfactant-associated proteins.

Authors:  T E Weaver; J A Whitsett
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

6.  Appropriate surfactant usage in 1996.

Authors:  R F Soll
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

Review 7.  Pulmonary surfactant and its apoproteins.

Authors:  S Hawgood; J A Clements
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 8.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

Review 9.  The fate of exogenous surfactant in neonates with respiratory distress syndrome.

Authors:  M Hallman; T A Merritt; K Bry
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

10.  Nebulization of liposomes. I. Effects of lipid composition.

Authors:  R W Niven; H Schreier
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.